Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Lung Cancer

Free Subscription Articles published in BMC Cancer Retrieve available abstracts of 77 articles: HTML format Text format

Single Articles

January 2012
1. SANZ-SANTOS J , Serra P, Andreo F, Llatjos M, et al
   Contribution of cell blocks obtained through endobronchial ultrasound-guided transbronchial needle aspiration to the diagnosis of lung cancer.
   BMC Cancer. 2012;12:34.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. ITO M , Niho S, Nihei K, Yoh K, et al
   Risk factors associated with fatal pulmonary hemorrhage in locally advanced non-small cell lung cancer treated with chemoradiotherapy.
   BMC Cancer. 2012;12:27.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. DOMINIONI L , Rotolo N, Mantovani W, Poli A, et al
   A population-based cohort study of chest x-ray screening in smokers: lung cancer detection findings and follow-up.
   BMC Cancer. 2012;12:18.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. SCHUETTE W , Tesch H, Buttner H, Krause T, et al
   Second-line Treatment of Stage III/IV Non-Small-Cell Lung Cancer (NSCLC) with pemetrexed in routine clinical practice: Evaluation of performance status and health-related quality of life.
   BMC Cancer. 2012;12:14.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
5. KUPERT E , Anderson M, Liu Y, Succop P, et al
   Plasma Secretory Phospholipase A2-IIa as a Potential Biomarker for Lung Cancer in Patients with Solitary Pulmonary Nodules.
   BMC Cancer. 2011;11:513.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
6. WU N , Li Q, Gu CX, Ahmed T, et al
   Paraneoplastic syndrome mimicking Adult-Onset Still's Disease caused by advanced lung cancer: a case report.
   BMC Cancer. 2011;11:487.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
7. KIYOHARA C , Horiuchi T, Takayama K, Nakanishi Y, et al
   Methylenetetrahydrofolate reductase polymorphisms and interaction with smoking and alcohol consumption in lung cancer risk: a case-control study in a Japanese population.
   BMC Cancer. 2011;11:459.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. GUAN X , Liao Z, Ma H, Qian J, et al
   TNFRSF1B +676 T>G polymorphism predicts survival of non-Small cell lung cancer patients treated with chemoradiotherapy.
   BMC Cancer. 2011;11:447.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. GLYNN RW , Kelly JC, Coffey N, Sweeney KJ, et al
   The effect of breast cancer awareness month on internet search activity - a comparison with awareness campaigns for lung and prostate cancer.
   BMC Cancer. 2011;11:442.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. WU YL , Park K, Soo RA, Sun Y, et al
    INSPIRE: A phase III study of the BLP25 liposome vaccine (L-BLP25) in Asian patients with unresectable stage III non-small cell lung cancer.
    BMC Cancer. 2011;11:430.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
11. WANGYU Z , Xiaoguang L, Jianying H, Dongdong C, et al
    Overexpression of members of the microRNA-183 family is a risk factor for lung cancer: a case control study.
    BMC Cancer. 2011;11:393.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
12. SHEN J , Liu Z, Todd NW, Zhang H, et al
    Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers.
    BMC Cancer. 2011;11:374.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. KAWAHARA M , Tada H, Tokoro A, Teramukai S, et al
    Quality-of-life evaluation for advanced non-small-cell lung cancer: a comparison between vinorelbine plus gemcitabine followed by docetaxel versus paclitaxel plus carboplatin regimens in a randomized trial: Japan Multinational Trial Organization LC00-
    BMC Cancer. 2011;11:356.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. BRAUN DP , Gupta D, Staren ED
    Quality of Life Assessment as a Predictor of Survival in Non-Small Cell Lung Cancer.
    BMC Cancer. 2011;11:353.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. KO YH , Won HS, Jeon EK, Hong SH, et al
    Prognostic Significance of CD44s Expression in Resected Non-Small Cell Lung Cancer.
    BMC Cancer. 2011;11:340.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. YU L , Hales CA
    Long-term exposure to hypoxia inhibits tumor progression of lung cancer in rats and mice.
    BMC Cancer. 2011;11:331.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
17. XIE ZH , Quan MF, Liu F, Cao JG, et al
    5-allyl-7-gen-difluoromethoxychrysin enhances TRAIL-induced apoptosis in human lung carcinoma A549 cells.
    BMC Cancer. 2011;11:322.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
18. ENGSIG FN , Kronborg G, Larsen CS, Pedersen G, et al
    Lung cancer in HIV patients and their parents: A Danish cohort study.
    BMC Cancer. 2011;11:272.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. HUERTA-YEPEZ S , Yoon NK, Hernandez-Cueto A, Mah V, et al
    Expression of Phosphorylated Raf Kinase Inhibitor Protein (pRKIP) is a Predictor of Lung Cancer Survival.
    BMC Cancer. 2011;11:259.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. WU NY , Cheng HC, Ko JS, Cheng YC, et al
    Magnetic Resonance Imaging for Lung Cancer Detection: Experience in a Population of More Than 10,000 Healthy Individuals.
    BMC Cancer. 2011;11:242.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. ROBEY IF , Martin NK
    Bicarbonate and dichloroacetate: Evaluating pH altering therapies in a mouse model for metastatic breast cancer.
    BMC Cancer. 2011;11:235.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. SLATORE CG , Gould MK, Au DH, Deffebach ME, et al
    Lung Cancer Stage at Diagnosis: Individual Associations in the Prospective VITamins And Lifestyle (VITAL) Cohort.
    BMC Cancer. 2011;11:228.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. CARPAGNANO GE , Palladino GP, Lacedonia D, Kouteluo A, et al
    Neutrophilic airways inflammation in lung cancer: the role of exhaled LTB-4 and IL-8.
    BMC Cancer. 2011;11:226.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
24. GRUTSCH JF , Ferrans C, Wood PA, Du-Quiton J, et al
    The Association of Quality of Life with Potentially Remediable Disruptions of Circadian Sleep/Activity Rhythms in Patients with Advanced Lung Cancer.
    BMC Cancer. 2011;11:193.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. ZHANG S , Wang Y, Dai SD, Wang EH, et al
    Down-regulation of NKD1 increases the invasive potential of non-small-cell lung cancer and correlates with a poor prognosis.
    BMC Cancer. 2011;11:186.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. WARTH A , Muley T, Meister M, Herpel E, et al
    Loss of aquaporin-4 expression and putative function in non-small cell lung cancer.
    BMC Cancer. 2011;11:161.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. ANDREJAK C , Terzi N, Thielen S, Bergot E, et al
    Admission of advanced lung cancer patients to intensive care unit: A retrospective study of 76 patients.
    BMC Cancer. 2011;11:159.
    PubMed     Text format     Related articles   
    
    
    
    April 2011
28. JI M , Guan H, Gao C, Shi B, et al
    Highly frequent promoter methylation and PIK3CA amplification in non-small cell lung cancer (NSCLC).
    BMC Cancer. 2011;11:147.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
29. SCHNEIDER KU , Dietrich D, Fleischhacker M, Leschber G, et al
    Correlation of SHOX2 Gene Amplification and DNA Methylation in Lung Cancer Tumors.
    BMC Cancer. 2011;11:102.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. NEWNHAM GM , Conron M, McLachlan SA, Dobrovic A, et al
    Integrated mutation, copy number and expression profiling in resectable non-small cell lung cancer.
    BMC Cancer. 2011;11:93.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. GUO R , Chen X, Wang T, Zhang Z, et al
    Subsequent chemotherapy reverses acquired tyrosine kinase inhibitor resistance and restores response to tyrosine kinase inhibitor in advanced non-small-cell lung cancer.
    BMC Cancer. 2011;11:90.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
32. WATANABE S , Tanaka J, Ota T, Kondo R, et al
    Clinical responses to EGFR-tyrosine kinase inhibitor retreatment in non-small cell lung cancer patients who benefited from prior effective gefitinib therapy: a retrospective analysis.
    BMC Cancer. 2011;11:1.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. RODRIGUEZ BL , Yu Z, Chung WG, Weiss R, et al
    Replicase-based plasmid DNA shows anti-tumor activity.
    BMC Cancer. 2011;11:110.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. SHI L , Tian H, McCarthy WJ, Berman B, et al
    Exploring the uncertainties of early detection results: model-based interpretation of mayo lung project.
    BMC Cancer. 2011;11:92.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. CENTENO I , Blay P, Santamaria I, Astudillo A, et al
    Germ-line mutations in epidermal growth factor receptor (EGFR) are rare but may contribute to oncogenesis: a novel germ-line mutation in EGFR detected in a patient with lung adenocarcinoma.
    BMC Cancer. 2011;11:172.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. KAWAKAMI T , Sameshima T, Hojo H, Koga K, et al
    Synthetic emmprin peptides with chitobiose substitution stimulate MMP-2 production by fibroblasts.
    BMC Cancer. 2011;11:300.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. TIMMERS L , Boons CC, Mangnus D, Moes JE, et al
    The use of erlotinib in daily practice: a study on adherence and patients' experiences.
    BMC Cancer. 2011;11:284.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. LEE YS , Kim TS, Kim DK
    T lymphocytes derived from human cord blood provide effective antitumor immunotherapy against a human tumor.
    BMC Cancer. 2011;11:225.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. TAMURA H , Suzuki M, Moriya Y, Hoshino H, et al
    Aberrant methylation of N-methyl-D-aspartate receptor type 2B (NMDAR2B) in non-small cell carcinoma.
    BMC Cancer. 2011;11:220.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
40. HSIEH CH , Chang HT, Lin SC, Chen YJ, et al
    Toxic risk of stereotactic body radiotherapy and concurrent helical tomotherapy followed by erlotinib for non-small-cell lung cancer treatment - case report.
    BMC Cancer. 2010;10:696.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. CHEN J , Xie F, Zhang L, Jiang WG, et al
    iASPP is over-expressed in human non-small cell lung cancer and regulates the proliferation of lung cancer cells through a p53 associated pathway.
    BMC Cancer. 2010;10:694.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. MAEDA J , Higashiyama M, Imaizumi A, Nakayama T, et al
    Possibility of multivariate function composed of plasma amino acid profiles as a novel screening index for non-small cell lung cancer: a case control study.
    BMC Cancer. 2010;10:690.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. HE L , Teng Y, Jin B, Zhao M, et al
    Initial partial response and stable disease according to RECIST indicate similar survival for chemotherapeutical patients with advanced non-small cell lung cancer.
    BMC Cancer. 2010;10:681.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
44. MORINI M , Astigiano S, Gitton Y, Emionite L, et al
    Mutually exclusive expression of DLX2 and DLX5/6 is associated with the metastatic potential of the human breast cancer cell line MDA-MB-231.
    BMC Cancer. 2010;10:649.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. LEWIS PD , Lewis KE, Ghosal R, Bayliss S, et al
    Evaluation of FTIR Spectroscopy as a diagnostic tool for lung cancer using sputum.
    BMC Cancer. 2010;10:640.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. PALLIS AG , Agelaki S, Agelidou A, Varthalitis I, et al
    A randomized phase III study of the docetaxel/carboplatin combination versus docetaxel single-agent as second line treatment for patients with advanced/metastatic Non-Small Cell Lung Cancer.
    BMC Cancer. 2010;10:633.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. WEI J , Zhao J, Long M, Han Y, et al
    p21WAF1/CIP1 gene transcriptional activation exerts cell growth inhibition and enhances chemosensitivity to cisplatin in lung carcinoma cell.
    BMC Cancer. 2010;10:632.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. YAN S , Shun-Chang J, Li C, Jie L, et al
    Topoisomerase II alpha expression and the benefit of adjuvant chemotherapy for postoperative patients with non-small cell lung cancer.
    BMC Cancer. 2010;10:621.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. SCHMIDT B , Liebenberg V, Dietrich D, Schlegel T, et al
    SHOX2 DNA Methylation is a Biomarker for the Diagnosis of Lung Cancer Based on Bronchial Aspirates.
    BMC Cancer. 2010;10:600.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
50. MAURYA DK , Doi C, Kawabata A, Pyle MM, et al
    Therapy with un-engineered naive rat umbilical cord matrix stem cells markedly inhibits growth of murine lung adenocarcinoma.
    BMC Cancer. 2010;10:590.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. AYDIN C , Sanlioglu AD, Bisgin A, Yoldas B, et al
    NF-kappaB targeting by way of IKK inhibition sensitizes lung cancer cells to adenovirus delivery of TRAIL.
    BMC Cancer. 2010;10:584.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
52. YANG F , Chen H, Xiang J, Zhang Y, et al
    Relationship between tumor size and disease stage in non-small cell lung cancer.
    BMC Cancer. 2010;10:474.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
53. SAN JOSE C , Cabanillas A, Benitez J, Carrillo JA, et al
    CYP1A1 gene polymorphisms increase lung cancer risk in a high-incidence region of Spain: a case control study.
    BMC Cancer. 2010;10:463.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. WOUTERS A , Pauwels B, Lardon F, Pattyn GG, et al
    In vitro study on the schedule-dependency of the interaction between pemetrexed, gemcitabine and irradiation in non-small cell lung cancer and head and neck cancer cells.
    BMC Cancer. 2010;10:441.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. RIEMSMA R , Simons JP, Bashir Z, Gooch CL, et al
    Systematic Review of topotecan (Hycamtin) in relapsed small cell lung cancer.
    BMC Cancer. 2010;10:436.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. BOUKAKIS G , Patrinou-Georgoula M, Lekarakou M, Valavanis C, et al
    Deregulated expression of hnRNP A/B proteins in human non-small cell lung cancer: parallel assessment of protein and mRNA levels in paired tumor /non-tumor tissues.
    BMC Cancer. 2010;10:434.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. GUAN X , Yin M, Wei Q, Zhao H, et al
    Genotypes and haplotypes of the VEGF gene and survival in locally advanced non-small cell lung cancer patients treated with chemoradiotherapy.
    BMC Cancer. 2010;10:431.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. JIN Y , Xu H, Zhang C, Kong Y, et al
    Combined effects of Cigarette Smoking, Gene Polymorphisms and Methylations of Tumor Suppressor Genes on Non Small Cell Lung Cancer: a Hospital-Based Case-Control Study in China.
    BMC Cancer. 2010;10:422.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2010
59. XIONG W , Ren ZG, Qiu SJ, Sun HC, et al
    Residual hepatocellular carcinoma after oxaliplatin treatment has increased metastatic potential in a nude mouse model and is attenuated by Songyou Yin.
    BMC Cancer. 2010;10:219.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2010
60. LUM AM , Wang BB, Beck-Engeser GB, Li L, et al
    Orphan receptor GPR110, an oncogene overexpressed in lung and prostate cancer.
    BMC Cancer. 2010;10:40.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2010
61. KALININA T , Gungor C, Thieltges S, Moller-Krull M, et al
    Establishment and characterization of a new human pancreatic adenocarcinoma cell line with high metastatic potential to the lung.
    BMC Cancer. 2010;10:295.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. BAKACS T , Mehrishi JN
    Breast and other cancer dormancy as a therapeutic endpoint: speculative recombinant T cell receptor ligand (RTL) adjuvant therapy worth considering?
    BMC Cancer. 2010;10:251.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. SHIAU AL , Teo ML, Chen SY, Wang CR, et al
    Inhibition of experimental lung metastasis by systemic lentiviral delivery of kallistatin.
    BMC Cancer. 2010;10:245.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. YI H , Cho HJ, Cho SM, Lee DG, et al
    Pharmacokinetic properties and antitumor efficacy of the 5-fluorouracil loaded PEG-hydrogel.
    BMC Cancer. 2010;10:211.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. GASSMANN P , Kang ML, Mees ST, Haier J, et al
    In vivo tumor cell adhesion in the pulmonary microvasculature is exclusively mediated by tumor cell--endothelial cell interaction.
    BMC Cancer. 2010;10:177.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. CHIA JS , Du JL, Hsu WB, Sun A, et al
    Inhibition of metastasis, angiogenesis, and tumor growth by Chinese herbal cocktail Tien-Hsien Liquid.
    BMC Cancer. 2010;10:175.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. TAI CJ , Wu AT, Chiou JF, Jan HJ, et al
    The investigation of mitogen-activated protein kinase phosphatase-1 as a potential pharmacological target in non-small cell lung carcinomas, assisted by non-invasive molecular imaging.
    BMC Cancer. 2010;10:95.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. NEUMANN J , Feuerhake F, Kayser G, Wiech T, et al
    Gene expression profiles of lung adenocarcinoma linked to histopathological grading and survival but not to EGF-R status: a microarray study.
    BMC Cancer. 2010;10:77.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. MELOTTI A , Daga A, Marubbi D, Zunino A, et al
    In vitro and in vivo characterization of highly purified human mesothelioma derived cells.
    BMC Cancer. 2010;10:54.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. AIZAWA J , Sakayama K, Kamei S, Kidani T, et al
    Effect of troglitazone on tumor growth and pulmonary metastasis development of the mouse osteosarcoma cell line LM8.
    BMC Cancer. 2010;10:51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. ZHANG S , Guo D, Luo W, Zhang Q, et al
    TrkB is highly expressed in NSCLC and mediates BDNF-induced the activation of Pyk2 signaling and the invasion of A549 cells.
    BMC Cancer. 2010;10:43.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. MASLIKOWSKI BM , Neel BD, Wu Y, Wang L, et al
    Cellular processes of v-Src transformation revealed by gene profiling of primary cells--implications for human cancer.
    BMC Cancer. 2010;10:41.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. ALTOMARE DA , Rybak SM, Pei J, Maizel JV, et al
    Onconase responsive genes in human mesothelioma cells: implications for an RNA damaging therapeutic agent.
    BMC Cancer. 2010;10:34.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. ROATO I , Caldo D, Godio L, D'Amico L, et al
    Bone invading NSCLC cells produce IL-7: mice model and human histologic data.
    BMC Cancer. 2010;10:12.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. STEMPFER R , Syed P, Vierlinger K, Pichler R, et al
    Tumour auto-antibody screening: performance of protein microarrays using SEREX derived antigens.
    BMC Cancer. 2010;10:627.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. HE L , Lu Y, Wang P, Zhang J, et al
    Up-regulated expression of type II very low density lipoprotein receptor correlates with cancer metastasis and has a potential link to beta-catenin in different cancers.
    BMC Cancer. 2010;10:601.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
77. XIE L , Chen X, Wang L, Qian X, et al
    Cell-free miRNAs may indicate diagnosis and docetaxel sensitivity of tumor cells in malignant effusions.
    BMC Cancer. 2010;10:591.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: